
Premature coronary artery disease (CAD) is an aggressive disease with a high rate of ischemic recurrences and premature death, researchers said.
Premature coronary artery disease (CAD) is an aggressive disease with a high rate of ischemic recurrences and premature death, researchers said.
A recent study sought to estimate the incidence of clinical events such as bleeding, myocardial infarction, and all-cause mortality in patients with acute myocardial infarction and chronic coronary syndrome who received dual antiplatelet therapy (DAPT) after coronary stenting.
Giving patients icosapent ethyl, or Vascepa, led to a 52% reduction of the total patient-reported symptom outcome prevalence score as compared with a 24% decline for outpatients who received usual care.
There was a significant decrease in the rates of cardiovascular complications and mortality in adults with diabetes in South Korea, but other conditions increased.
Despite heavy alcohol consumption being linked to increased incidence of atrial fibrillation (AF) and bleeding in patients with the condition, recommendations to control heavy drinking among this patient population are lacking.
Childhood abuse, household dysfunction, and neglect were linked in a recent study to an increased risk of developing cardiovascular disease in adulthood.
A recent prospective, observational study investigated the use of direct oral anticoagulants for use in patients with postoperative atrial fibrillation and found favorable safety and efficacy results.
The use of a population health management tool may reduce adverse events that may arise from the inappropriate prescribing of direct-acting oral anticoagulants (DOACs).
It remains unclear whether measures of magnetic resonance imaging plaque characteristics are associated with cardiovascular disease events independent of plaque burden at the population level.
Financial toxicity, ACO contracts, removing barriers to care.
From the Oncology Care Model to the possibilities of cannabis, policy issues drew big crowds at the 2019 Annual Meeting of the American Society of Clinical Oncology.
Cytokine release syndrome represents a major concern, and source of costs, associated with the life-saving gene therapy.
Real-world evidence is being embraced by FDA as a way to expand the review of data beyond the trial population, which may not be representative of the patients seen in clinics on a daily basis.
Early detection and treatment of lung cancer through screening with low-dose computed tomography (CT) has been investigated as a potential tool for reducing lung cancer deaths, the leading cause of cancer death worldwide, for more than 2 decades. Published this week was an extended follow up study to the 2011 randomized National Lung Screening Trial that found a similar number of patients must be screened to prevent cancer deaths as determined in the original analysis.
In a session held during the Florida Society of Clinical Oncology’s annual meeting in April, panelist James Almas, MD, vice president and national medical director of clinical effectiveness at LabCorp, and previously a medical officer at CMS in the Coverage Analysis Group, announced that he expected the National Coverage Determination to be reopened for Foundation Medicine’s FDA-approved companion diagnostic. By the end of the month, CMS revealed that they had done just that.
A recent study sought to determine if there was an association between food insecurity, or the fear that your food will run out before you have enough money to purchase more, and migraine, which commonly affects 1 in 6 individuals, among young adults in the United States.
Impulsive and compulsive behaviors have become increasingly associated with Parkinson disease (PD) and treatment. Recently, the International Parkinson’s and Movement Disorder Society commissioned a task force to assess currently available screening tools and rating scales in order to make recommendations regarding their utility, as well as to inform future directions in scale development and validation.
Researchers have found additional evidence that Parkinson disease initiates among cells in the gut and then travels through the body’s vagus nerve to the brain, according to a recently published study conducted in mice models.
According to a new study, the speed at which older patients with blood cancers are able to walk nearly 13 feet (about 4 meters) contains important information about their overall health and may be able to help predict survival and unplanned hospital visits.
OBR hosted a webinar that featured a discussion about how oncology practices can leverage artificial intelligence (AI) to improve cancer care.
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.
Coverage from The American Journal of Managed Care's® Institue for Value-Based Medicine® meetings.
According to a study published earlier this week, nearly 95% of healthcare workers risk potentially transmitting respiratory viruses to both patients and coworkers by attending work even when they show symptoms.
According to new research published this week, investigators have identified the earliest signs of Parkinson disease (PD) in the brain, years before patients present with any symptoms.
Conference coverage from the annual meeting's of the Florida Society of Clinical Oncology's annual meeting and ISPOR.
According to a study published today in the New England Journal of Medicine of the first quantitative evidence on the nation’s first work requirements in Medicaid, thousands of adults lost insurance coverage in the 6 months after the requirements were implemented, with no change in employment.
According to results from a randomized phase 3 trial presented at the American Society of Clinical Oncology’s recent annual meeting, the addition of isatuximab to pomalidomide and low-dose dexamethasone significantly improvement progression-free survival (PFS) and the overall response rate (ORR) in patients with relapsed or refractory multiple myeloma (RRMM).
According to a recent study presented at the American Thoracic Society International Conference in Dallas, Texas, and simultaneously published in the New England Journal of Medicine, nearly three-fourths of patients with mild, persistent asthma had a low sputum eosinophil levels and did not differ in their response to either mometasone or tiotropium when compared with placebo.
Published: November 22nd 2017 | Updated:
Published: November 29th 2017 | Updated:
Published: December 1st 2017 | Updated:
Published: December 5th 2017 | Updated:
Published: December 6th 2017 | Updated:
Published: December 7th 2017 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.